Kitty Whitney News Today

Major pharmaceutical companies are increasingly turning to artificial intelligence (AI) to revolutionize drug development processes

Since the Coronavirus pandemic struck, approximately 90% of pharma companies have initiated artificial intelligence projects focused on a range of major areas such as immuno-oncology and metabolic diseases.

Drug companies look to AI to end hit and miss research Julia Kollewe © Provided by The Guardian Photograph: Sakchai Lalit/AP The hunt for new medicines has often been more like a game of roulette than high-end science. But now the pharmaceutical sector is on the cusp of a transformation, as it delves into cutting-edge technology to come up with new treatments for diseases such as cancer, rheumatoid arthritis and Alzheimer’s. Artificial intelligence (AI) is set to improve th...